The US Food and Drug Administration (FDA) has formally given Neuralink, Elon Musk’s brain-chip company, approval for its first human trials.
The billionaire’s Neuralink implant company seeks to help people regain their vision and mobility via linking brains with computers. The chips, which have undergone successful testing on monkeys, are able to decipher brain signals and send data to devices through Bluetooth.
On Thursday, Neuralink tweeted the news, describing it as “an important first step that will one day allow our technology to help many people.”
Neuralink announced the news on Twitter on Thursday, calling it a “important first step that will one day allow our technology to help many people.”
According to the company, the approval was the “result of incredible work by the Neuralink team in close collaboration with the FDA.”
Neuralink’s previous attempt for FDA approval was denied due to safety concerns. But since then, the business has made significant progress, and Neuralink’s diligence and collaboration with the FDA led to the the latest clearance from the agency.
Despite not currently having plans in place to find participants for the trials, Neuralink is eager to make its technology accessible to a wide spectrum of individuals in the future. The need of reliability, accessibility, and safety is paramount during the engineering process.
Despite not currently having plans in place to find participants for the trials, Neuralink is eager to make its technology accessible to a wide spectrum of individuals in the future. The need of reliability, accessibility, and safety is paramount during the engineering process.
The company pledged to give further information about their intentions to find study participants “soon.”
As stated on its website, the engineering approach gives “safety, accessibility, and reliability” first priority.
Experts have warned that if Neuralink’s brain implants are to become generally available, they will need considerable testing to overcome technological and ethical challenges.
The news from Neuralink follows an intriguing development by Swiss researchers who developed a system of brain implants that allow a paralyzed man to walk merely by thinking about it. This success exemplifies how dramatically brain-computer interfaces may improve the lives of people with impairments.
Source: BBC, Roundnews24
